Fabienne Dominjon
Servier (France)(FR)Institut de Relations Internationales et Stratégiques(FR)
Publications by Year
Research Areas
Heart rate and cardiovascular health, Heart Failure Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Cardiac pacing and defibrillation studies, Advanced Causal Inference Techniques
Most-Cited Works
- → Effect of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction: The Edify Randomized Placebo-Controlled Trial(2017)195 cited
- → Traditional and New Composite Endpoints in Heart Failure Clinical Trials: Facilitating Comprehensive Efficacy Assessments and Improving Trial Efficiency(2016)93 cited
- → Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris(2016)19 cited
- → Erratum to “Traditional and New Composite Endpoints in Heart Failure Clinical Trials: Facilitating Comprehensive Efficacy Assessments and Improving Trial Efficiency” [Eur J Heart Fail 2016;18:482-489](2016)3 cited
- → BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY(2015)3 cited
- → Effects of Heart Rate Reduction in Black Patients from the SHIFT (Systolic Heart Failure treatment with the If Inhibitor Ivabradine Trial) Study(2015)1 cited
- Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency (vol 18, pg 482, 2016)(2016)
- → Abstract 18395: Safety of Continuing Ivabradine Treatment During Hospitalization for Worsening of Heart Failure in the SHIFT Study(2015)